Drugs / Ex-vivo Expanded γδ T Lymphocytes
last change Jan 2023 re-read 3 minutes ago

Ex-vivo Expanded γδ T Lymphocytes

Developed for
acute myeloid leukemia
Investigated by
Jinan University, China · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT04008381 Sep 2019 → Jul 2022 acute myeloid leukemia Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ex-vivo Expanded γδ T Lymphocytes ClinicalTrials.gov intervention name — accepted as the source's own label NCT04008381 ↗